🎥@ldawsonmd of @UofT discusses SBRT for localized colorectal cancers, emphasizing its potential to improve survival. SBRT should complement, not replace, surgery and systemic therapies:

➡️⬅️

@myESMO #ESMOGI24 #RadOnc #CRCsm #ColorectalCancer

Stereotactic body radiation therapy for treating colon cancer

Laura Dawson, MD, University of Toronto, Toronto, Canada, discusses stereotactic body radiation therapy (SBRT) for treat...

ow.ly

🎥@AlexisLevee of @CityofHope discusses a study on gut microbiome's link to response in metastatic #breastcancer treated with ICIs. Future studies aim to personalize treatments and develop probiotics:

➡️⬅️

@ASCO @OncoAlert #ASCO24 #ImmunoOnc #BCsm

Using gut microbiota to enhance immunotherapy for breast cancer

Alexis Ann LeVee, MD, City of Hope, Duarte, CA, comments on a Phase I/II study (NCT02778685) that revealed the g...

ow.ly

🎥@drlauragoff of @VUMC_Cancer discusses the CheckMate 9DW trial, showing nivolumab + ipilimumab improved OS in advanced HCC vs. sorafenib or lenvatinib, outperforming IMbrave150 and HIMALAYA trials:

➡️⬅️

@ASCO @OncoAlert #ASCO24 #CTSM #ImmunoOnc #HPBCsm

CheckMate 9DW: the future of checkpoint inhibitors in advanced HCC

Laura Williams Goff, MD, MSCI, MMHC, Vanderbilt-Ingram Cancer Center, Nashville, TN, provides insight on the CheckMate ...

ow.ly

JULY is #Sarcoma Awareness Month 📣 💡

Check out this interview with Vaishali Kumar, MBBS from #AACR2024 | CCNG1 as a #biomarker for DRG-101 gene therapy in #cancer 🎥 🔦

👉

#VJOncology #Oncologynews #SarcomaAwarenessMonth

CCNG1 as a biomarker for DRG-101 gene therapy in cancer

Vaishali Kumar, MBBS, Sarcoma Oncology Research Center, Santa Monica, CA, discusses findings from an analysis of CCNG1...

www.vjoncology.com

🎥@ChiaraCrem1 of @Unipisa discusses HRQoL from the CheckMate 8HW study on first-line nivolumab + ipilimumab vs. chemo in MSI-H/dMMR mCRC. Checkpoint inhibitors improved HRQoL significantly:

➡️⬅️

#ESMOGI24 @myESMO #CTSM #ImmunoOnc #CRCsm

CheckMate 8HW: HRQoL outcomes of nivolumab and ipilimumab in MSI-H/dMMR mCRC

Chiara Cremolini, MD, PhD, University of Pisa, Pisa, Italy, discusses the health-related quality of life (HRQoL) outco...

ow.ly